ExpreS2ion Biotech Holding AB Financial Flexibility Index
ExpreS2ion Biotech Holding AB financial flexibility index. ExpreS2ion Biotech Holding AB (EXPRS2) has a Financial Flexibility Index of 0.00x as of March 2026. Free cash flow of Skr0.00 (operating CF Skr-25.49 Million minus capex Skr25.49 Million) represents 0% of total liabilities (Skr23.98 Million). See EXPRS2 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ExpreS2ion Biotech Holding AB (2016–2025)
Financial flexibility index of ExpreS2ion Biotech Holding AB from 2016 to 2025. Historical Financial Flexibility Index trend for ExpreS2ion Biotech Holding AB across 10 annual periods. Explore EXPRS2 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
ExpreS2ion Biotech Holding AB Financial Flexibility Index by Year (2016–2025)
ExpreS2ion Biotech Holding AB financial flexibility index by year from 2016 to 2025. Year-by-year free cash flow to debt coverage for ExpreS2ion Biotech Holding AB. For the full cash flow conversion analysis, see cash flow conversion of ExpreS2ion Biotech Holding AB.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.39x | Skr-40.90 Million | Skr-40.90 Million | Skr29.42 Million | ▼ -68.7% |
| 2024 | -0.82x | Skr-33.06 Million | Skr-33.93 Million | Skr40.11 Million | ▲ +88.9% |
| 2023 | -7.42x | Skr-98.87 Million | Skr-100.89 Million | Skr13.33 Million | ▼ -154.4% |
| 2022 | -2.92x | Skr-99.23 Million | Skr-99.61 Million | Skr34.04 Million | ▲ +24.7% |
| 2021 | -3.87x | Skr-44.93 Million | Skr-45.65 Million | Skr11.61 Million | ▼ -444.1% |
| 2020 | -0.71x | Skr-17.29 Million | Skr-18.18 Million | Skr24.31 Million | ▼ -17.2% |
| 2019 | -0.61x | Skr-12.01 Million | Skr-12.69 Million | Skr19.79 Million | ▲ +36.3% |
| 2018 | -0.95x | Skr-12.07 Million | Skr-12.88 Million | Skr12.65 Million | ▼ -19.1% |
| 2017 | -0.80x | Skr-8.40 Million | Skr-8.61 Million | Skr10.50 Million | ▼ -49.1% |
| 2016 | -0.54x | Skr-6.30 Million | Skr-7.02 Million | Skr11.73 Million | — |